Evidence map›Paper›PMID 32610121›Full record

ArticleCell reports2020

Adipocyte-Derived Versican and Macrophage-Derived Biglycan Control Adipose Tissue Inflammation in Obesity.

Chang Yeop Han, Inkyung Kang, Ingrid A Harten, John A Gebe, Christina K Chan, Mohamed Omer, Kimberly M Alonge, Laura J den Hartigh, Diego Gomes Kjerulf, Leela Goodspeed and 6 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Obesity-associated inflammatory macrophage polarization is inhibited by capsaicin and phytolignans.American journal of physiology. Regulatory, integrative and comparative physiology · 2024
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Chang Yeop HanDepartment of Medicine, Division of Metabolism, Endocrinology, and Nutrition, University of Washington, Seattle, WA, USA.
Inkyung KangMatrix Biology Program, Benaroya Research Institute, Seattle, WA, USA.
Ingrid A HartenMatrix Biology Program, Benaroya Research Institute, Seattle, WA, USA.
John A GebeMatrix Biology Program, Benaroya Research Institute, Seattle, WA, USA.
Christina K ChanMatrix Biology Program, Benaroya Research Institute, Seattle, WA, USA.
Mohamed OmerDepartment of Medicine, Division of Metabolism, Endocrinology, and Nutrition, University of Washington, Seattle, WA, USA.
Kimberly M AlongeDepartment of Medicine, Division of Metabolism, Endocrinology, and Nutrition, University of Washington, Seattle, WA, USA.
Laura J den HartighDepartment of Medicine, Division of Metabolism, Endocrinology, and Nutrition, University of Washington, Seattle, WA, USA.
Diego Gomes KjerulfDepartment of Medicine, Division of Metabolism, Endocrinology, and Nutrition, University of Washington, Seattle, WA, USA.
Leela GoodspeedDepartment of Medicine, Division of Metabolism, Endocrinology, and Nutrition, University of Washington, Seattle, WA, USA.
Savitha SubramanianDepartment of Medicine, Division of Metabolism, Endocrinology, and Nutrition, University of Washington, Seattle, WA, USA.
Shari WangDepartment of Medicine, Division of Metabolism, Endocrinology, and Nutrition, University of Washington, Seattle, WA, USA.
Francis KimDivision of Cardiology, University of Washington, Seattle, WA, USA.
David E BirkDepartment of Molecular Pharmacology & Physiology, University of South Florida, Tampa, FL, USA.
Thomas N WightMatrix Biology Program, Benaroya Research Institute, Seattle, WA, USA.
Alan ChaitDepartment of Medicine, Division of Metabolism, Endocrinology, and Nutrition, University of Washington, Seattle, WA, USA. Electronic address: achait@uw.edu.
University of Washington · USMatrix Research (United States) · USUniversity of South Florida · US

Funding

Vector and Transgenic Mouse CoreP30DK017047 · NIDDK · UNIVERSITY OF WASHINGTON · PI Karin E Bornfeldt · 1986 to 2026
$41.4M
PILOT STUDY--CLINICAL NUTRITION RESEARCHP30DK035816 · NIDDK · UNIVERSITY OF WASHINGTON · PI Ellen A Schur · 1986 to 2026
$30.4M
Role of Serum Amyloid A in Diabetic Vascular DiseaseP01HL092969 · NHLBI · UNIVERSITY OF WASHINGTON · PI BORNFELDT, KARIN E. · 2008 to 2019
$23.5M
REVERSE CHOLESTEROL TRANSPORT IN DIABETESP01DK002456 · NIDDK · UNIVERSITY OF WASHINGTON · PI CHAIT, ALAN · 1986 to 2007
$10.2M
Regulation of the Innate Immune Response by the Epithelium in AsthmaU19AI125378 · NIAID · BENAROYA RESEARCH INST AT VIRGINIA MASON · PI CAMPBELL, DANIEL J · 2016 to 2020
$9.2M
Nutrition, Obesity and Atherosclerosis Training ProgramT32HL007028 · NHLBI · UNIVERSITY OF WASHINGTON · PI Karin E Bornfeldt · 1985 to 2026
$6.4M
Regulation of Allergen-Induced Airway Pathophysiology by VersicanR01AI130280 · NIAID · UNIVERSITY OF WASHINGTON · PI FREVERT, CHARLES WAYNE, HALLSTRAND, TEAL S · 2019 to 2023
$3.8M
Novel role of hypothalamic perineuronal nets in the pathogenesis of type 2 diabetesF32DK122662 · NIDDK · UNIVERSITY OF WASHINGTON · PI ALONGE, KIMBERLY MICHELE · 2019 to 2019
$62k
NHLBI NIH HHS P01 HL092969NHLBI NIH HHS T32 HL007028NIAID NIH HHS R01 AI130280NIAID NIH HHS U19 AI125378NIDDK NIH HHS F32 DK122662NIDDK NIH HHS P01 DK002456NIDDK NIH HHS P30 DK017047NIDDK NIH HHS P30 DK035816
6 · The paper itself

Abstract

Obesity is characterized by adipose tissue inflammation. Because proteoglycans regulate inflammation, here we investigate their role in adipose tissue inflammation in obesity. We find that adipose tissue versican and biglycan increase in obesity. Versican is produced mainly by adipocytes and biglycan by adipose tissue macrophages. Both proteoglycans are also present in adipose tissue from obese human subjects undergoing gastric bypass surgery. Deletion of adipocyte-specific versican or macrophage-specific biglycan in mice reduces macrophage accumulation and chemokine and cytokine expression, although only adipocyte-specific versican deletion leads to sustained improvement in glucose tolerance. Macrophage-derived biglycan activates inflammatory genes in adipocytes. Versican expression increases in cultured adipocytes exposed to excess glucose, and adipocyte-conditioned medium stimulates inflammation in resident peritoneal macrophages, in part because of a versican breakdown product, versikine. These findings provide insights into the role of adipocyte- and macrophage-derived proteoglycans in adipose tissue inflammation in obesity.

Indexed as

3T3-L1 CellsAdipocytesAdipose TissueAnimalsBiglycanBone MarrowDiet, High-FatFemaleGlucose Tolerance TestHumansHypertrophyInflammationInsulin ResistanceLiverMacrophagesMaleBiglycanRNA, MessengerVersicansadipose tissue inflammationbiglycaninsulin resistanceobesityproteoglycansversican

Identifiers

PMID32610121
PMCPMC7384517
OpenAlexW3039166536

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.